Back to Search Start Over

Multi-PheWAS intersection approach to identify sex differences across comorbidities in 59 140 pediatric patients with autism spectrum disorder

Authors :
Gutiérrez-Sacristán, Alba
Sáez, Carlos
De Niz, Carlos
Jalali, Niloofar
DeSain, Thomas N.
Kumar, Ranjay
Zachariasse, Joany M.
Fox, Kathe P.
Palmer, Nathan
Kohane, Isaac
Avillach, Paul
Gutiérrez-Sacristán, Alba
Sáez, Carlos
De Niz, Carlos
Jalali, Niloofar
DeSain, Thomas N.
Kumar, Ranjay
Zachariasse, Joany M.
Fox, Kathe P.
Palmer, Nathan
Kohane, Isaac
Avillach, Paul
Source :
Gutiérrez-Sacristán , A , Sáez , C , De Niz , C , Jalali , N , DeSain , T N , Kumar , R , Zachariasse , J M , Fox , K P , Palmer , N , Kohane , I & Avillach , P 2022 , ' Multi-PheWAS intersection approach to identify sex differences across comorbidities in 59 140 pediatric patients with autism spectrum disorder ' , Journal of the American Medical Informatics Association : JAMIA , vol. 29 , no. 2 , pp. 230-238 .
Publication Year :
2022

Abstract

OBJECTIVE: To identify differences related to sex and define autism spectrum disorder (ASD) comorbidities female-enriched through a comprehensive multi-PheWAS intersection approach on big, real-world data. Although sex difference is a consistent and recognized feature of ASD, additional clinical correlates could help to identify potential disease subgroups, based on sex and age. MATERIALS AND METHODS: We performed a systematic comorbidity analysis on 1860 groups of comorbidities exploring all spectrum of known disease, in 59 140 individuals (11 440 females) with ASD from 4 age groups. We explored ASD sex differences in 2 independent real-world datasets, across all potential comorbidities by comparing (1) females with ASD vs males with ASD and (2) females with ASD vs females without ASD. RESULTS: We identified 27 different comorbidities that appeared significantly more frequently in females with ASD. The comorbidities were mostly neurological (eg, epilepsy, odds ratio [OR] > 1.8, 3-18 years of age), congenital (eg, chromosomal anomalies, OR > 2, 3-18 years of age), and mental disorders (eg, intellectual disability, OR > 1.7, 6-18 years of age). Novel comorbidities included endocrine metabolic diseases (eg, failure to thrive, OR = 2.5, ages 0-2), digestive disorders (gastroesophageal reflux disease: OR = 1.7, 6-11 years of age; and constipation: OR > 1.6, 3-11 years of age), and sense organs (strabismus: OR > 1.8, 3-18 years of age). DISCUSSION: A multi-PheWAS intersection approach on real-world data as presented in this study uniquely contributes to the growing body of research regarding sex-based comorbidity analysis in ASD population. CONCLUSIONS: Our findings provide insights into female-enriched ASD comorbidities that are potentially important in diagnosis, as well as the identification of distinct comorbidity patterns influencing anticipatory treatment or referrals. The code is publicly available (https://github.com/hms-dbmi/sexDifferenceInASD)

Details

Database :
OAIster
Journal :
Gutiérrez-Sacristán , A , Sáez , C , De Niz , C , Jalali , N , DeSain , T N , Kumar , R , Zachariasse , J M , Fox , K P , Palmer , N , Kohane , I & Avillach , P 2022 , ' Multi-PheWAS intersection approach to identify sex differences across comorbidities in 59 140 pediatric patients with autism spectrum disorder ' , Journal of the American Medical Informatics Association : JAMIA , vol. 29 , no. 2 , pp. 230-238 .
Notes :
application/pdf, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1313639719
Document Type :
Electronic Resource